Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
G to A hypermutation of hepatitis B virus.
Noguchi C, Ishino H, Tsuge M, Fujimoto Y, Imamura M, Takahashi S, Chayama K. Noguchi C, et al. Among authors: imamura m. Hepatology. 2005 Mar;41(3):626-33. doi: 10.1002/hep.20580. Hepatology. 2005. PMID: 15726649
[HCV-HBV infection].
Imamura M, Chayama K. Imamura M, et al. Nihon Rinsho. 2006 Jul;64(7):1310-3. Nihon Rinsho. 2006. PMID: 16838649 Review. Japanese.
Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif.
Yatsuji H, Noguchi C, Hiraga N, Mori N, Tsuge M, Imamura M, Takahashi S, Iwao E, Fujimoto Y, Ochi H, Abe H, Maekawa T, Tateno C, Yoshizato K, Suzuki F, Kumada H, Chayama K. Yatsuji H, et al. Among authors: imamura m. Antimicrob Agents Chemother. 2006 Nov;50(11):3867-74. doi: 10.1128/AAC.00239-06. Epub 2006 Sep 18. Antimicrob Agents Chemother. 2006. PMID: 16982790 Free PMC article.
Dual effect of APOBEC3G on Hepatitis B virus.
Noguchi C, Hiraga N, Mori N, Tsuge M, Imamura M, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, Yatsuji H, Shirakawa K, Takaori-Kondo A, Chayama K. Noguchi C, et al. Among authors: imamura m. J Gen Virol. 2007 Feb;88(Pt 2):432-440. doi: 10.1099/vir.0.82319-0. J Gen Virol. 2007. PMID: 17251560
Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon.
Hiraga N, Imamura M, Tsuge M, Noguchi C, Takahashi S, Iwao E, Fujimoto Y, Abe H, Maekawa T, Ochi H, Tateno C, Yoshizato K, Sakai A, Sakai Y, Honda M, Kaneko S, Wakita T, Chayama K. Hiraga N, et al. Among authors: imamura m. FEBS Lett. 2007 May 15;581(10):1983-7. doi: 10.1016/j.febslet.2007.04.021. Epub 2007 Apr 20. FEBS Lett. 2007. PMID: 17466983 Free article.
Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma.
Jeong SC, Aikata H, Katamura Y, Azakami T, Kawaoka T, Saneto H, Uka K, Mori N, Takaki S, Kodama H, Waki K, Imamura M, Shirakawa H, Kawakami Y, Takahashi S, Chayama K. Jeong SC, et al. Among authors: imamura m. World J Gastroenterol. 2007 Oct 28;13(40):5343-50. doi: 10.3748/wjg.v13.i40.5343. World J Gastroenterol. 2007. PMID: 17879404 Free PMC article.
Successful treatment of an entecavir-resistant hepatitis B virus variant.
Yatsuji H, Hiraga N, Mori N, Hatakeyama T, Tsuge M, Imamura M, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, Suzuki F, Kumada H, Chayama K. Yatsuji H, et al. Among authors: imamura m. J Med Virol. 2007 Dec;79(12):1811-7. doi: 10.1002/jmv.20981. J Med Virol. 2007. PMID: 17935165
2,346 results